Cargando…
Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches
SIMPLE SUMMARY: Prostate cancer affects men of all racial and ethnic groups and leads to higher rates of mortality in those belonging to a lower socioeconomic status due to late detection of the disease. There is growing evidence that suggests the contribution of an individual’s genetic profile to p...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457814/ https://www.ncbi.nlm.nih.gov/pubmed/36080493 http://dx.doi.org/10.3390/molecules27175730 |
_version_ | 1784786148552343552 |
---|---|
author | Sekhoacha, Mamello Riet, Keamogetswe Motloung, Paballo Gumenku, Lemohang Adegoke, Ayodeji Mashele, Samson |
author_facet | Sekhoacha, Mamello Riet, Keamogetswe Motloung, Paballo Gumenku, Lemohang Adegoke, Ayodeji Mashele, Samson |
author_sort | Sekhoacha, Mamello |
collection | PubMed |
description | SIMPLE SUMMARY: Prostate cancer affects men of all racial and ethnic groups and leads to higher rates of mortality in those belonging to a lower socioeconomic status due to late detection of the disease. There is growing evidence that suggests the contribution of an individual’s genetic profile to prostate cancer. Currently used prostate cancer treatments have serious adverse effects; therefore, new research is focusing on alternative treatment options such as the use of genetic biomarkers for targeted gene therapy, nanotechnology for controlled targeted treatment, and further exploring medicinal plants for new anticancer agents. In this review, we describe the recent advances in prostate cancer research. ABSTRACT: Prostate cancer is one of the malignancies that affects men and significantly contributes to increased mortality rates in men globally. Patients affected with prostate cancer present with either a localized or advanced disease. In this review, we aim to provide a holistic overview of prostate cancer, including the diagnosis of the disease, mutations leading to the onset and progression of the disease, and treatment options. Prostate cancer diagnoses include a digital rectal examination, prostate-specific antigen analysis, and prostate biopsies. Mutations in certain genes are linked to the onset, progression, and metastasis of the cancer. Treatment for localized prostate cancer encompasses active surveillance, ablative radiotherapy, and radical prostatectomy. Men who relapse or present metastatic prostate cancer receive androgen deprivation therapy (ADT), salvage radiotherapy, and chemotherapy. Currently, available treatment options are more effective when used as combination therapy; however, despite available treatment options, prostate cancer remains to be incurable. There has been ongoing research on finding and identifying other treatment approaches such as the use of traditional medicine, the application of nanotechnologies, and gene therapy to combat prostate cancer, drug resistance, as well as to reduce the adverse effects that come with current treatment options. In this article, we summarize the genes involved in prostate cancer, available treatment options, and current research on alternative treatment options. |
format | Online Article Text |
id | pubmed-9457814 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94578142022-09-09 Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches Sekhoacha, Mamello Riet, Keamogetswe Motloung, Paballo Gumenku, Lemohang Adegoke, Ayodeji Mashele, Samson Molecules Review SIMPLE SUMMARY: Prostate cancer affects men of all racial and ethnic groups and leads to higher rates of mortality in those belonging to a lower socioeconomic status due to late detection of the disease. There is growing evidence that suggests the contribution of an individual’s genetic profile to prostate cancer. Currently used prostate cancer treatments have serious adverse effects; therefore, new research is focusing on alternative treatment options such as the use of genetic biomarkers for targeted gene therapy, nanotechnology for controlled targeted treatment, and further exploring medicinal plants for new anticancer agents. In this review, we describe the recent advances in prostate cancer research. ABSTRACT: Prostate cancer is one of the malignancies that affects men and significantly contributes to increased mortality rates in men globally. Patients affected with prostate cancer present with either a localized or advanced disease. In this review, we aim to provide a holistic overview of prostate cancer, including the diagnosis of the disease, mutations leading to the onset and progression of the disease, and treatment options. Prostate cancer diagnoses include a digital rectal examination, prostate-specific antigen analysis, and prostate biopsies. Mutations in certain genes are linked to the onset, progression, and metastasis of the cancer. Treatment for localized prostate cancer encompasses active surveillance, ablative radiotherapy, and radical prostatectomy. Men who relapse or present metastatic prostate cancer receive androgen deprivation therapy (ADT), salvage radiotherapy, and chemotherapy. Currently, available treatment options are more effective when used as combination therapy; however, despite available treatment options, prostate cancer remains to be incurable. There has been ongoing research on finding and identifying other treatment approaches such as the use of traditional medicine, the application of nanotechnologies, and gene therapy to combat prostate cancer, drug resistance, as well as to reduce the adverse effects that come with current treatment options. In this article, we summarize the genes involved in prostate cancer, available treatment options, and current research on alternative treatment options. MDPI 2022-09-05 /pmc/articles/PMC9457814/ /pubmed/36080493 http://dx.doi.org/10.3390/molecules27175730 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Sekhoacha, Mamello Riet, Keamogetswe Motloung, Paballo Gumenku, Lemohang Adegoke, Ayodeji Mashele, Samson Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches |
title | Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches |
title_full | Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches |
title_fullStr | Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches |
title_full_unstemmed | Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches |
title_short | Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches |
title_sort | prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457814/ https://www.ncbi.nlm.nih.gov/pubmed/36080493 http://dx.doi.org/10.3390/molecules27175730 |
work_keys_str_mv | AT sekhoachamamello prostatecancerreviewgeneticsdiagnosistreatmentoptionsandalternativeapproaches AT rietkeamogetswe prostatecancerreviewgeneticsdiagnosistreatmentoptionsandalternativeapproaches AT motloungpaballo prostatecancerreviewgeneticsdiagnosistreatmentoptionsandalternativeapproaches AT gumenkulemohang prostatecancerreviewgeneticsdiagnosistreatmentoptionsandalternativeapproaches AT adegokeayodeji prostatecancerreviewgeneticsdiagnosistreatmentoptionsandalternativeapproaches AT mashelesamson prostatecancerreviewgeneticsdiagnosistreatmentoptionsandalternativeapproaches |